Japan approves Viatris sleep drug Wakix for narcolepsy and sleep apnea

Go back to Japan approves Viatris sleep drug Wakix for narcolepsy and sleep apnea

Viatris Announces Approval of WAKIX® (Pitolisant) in Japan, a First-in-Class Treatment for Narcolepsy and Excessive Daytime Sleepiness Associated With Obstructive Sleep Apnea Syndrome

September 16, 2026 6:59 AM EDT

Approval Addresses High Unmet Medical Need and Further Advances Viatris' Innovative Portfolio in Japan

PITTSBURGH, Sept. 16, 2026 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced... More